search
Back to results

Efficacy of Sublingual Midazolam in Association With Oral Morphine in Children Analgesia After Bone Fracture (MIDAZODOL)

Primary Purpose

Fractures

Status
Completed
Phase
Phase 3
Locations
France
Study Type
Interventional
Intervention
Midazolam
Placebo
Sponsored by
Assistance Publique - Hôpitaux de Paris
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Fractures focused on measuring midazolam, sublingual, oral morphine, children, bone fracture, bone fracture with a deformed member

Eligibility Criteria

5 Years - 16 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • children between 5 and 16 years old
  • children with a disjoined bone fracture
  • children needed oral morphine analgesia
  • written informed consent from one or the two parents or legal pad

Exclusion Criteria:

  • ASA score > 2
  • concomitant administration of oral analgesia (level II WHO classification) less than 6 hours
  • concomitant administration of benzodiazepine less than 24 hours

Sites / Locations

  • Hopital Necker enfants Malade - Department of Pediatric Emergency

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

1

2

Arm Description

Midazolam and morphine

placebo, Nacl 0.9 %, morphine 0.5 mg/kg

Outcomes

Primary Outcome Measures

Difference in the measurement of pain analogical scale values at 30 minutes between the two groups

Secondary Outcome Measures

Pain Analogical scale Values at 15, 30 minutes, 1 hour, 1h30 and 2 hours.
Pain Analogical scale Values after the treatment of the fracture
Respiratory rate, Oxymetry
Conscience (lethargy or irritability)
nausea,
skin hyperesthesia, rash
children cooperation

Full Information

First Posted
December 26, 2006
Last Updated
August 27, 2013
Sponsor
Assistance Publique - Hôpitaux de Paris
search

1. Study Identification

Unique Protocol Identification Number
NCT00416039
Brief Title
Efficacy of Sublingual Midazolam in Association With Oral Morphine in Children Analgesia After Bone Fracture
Acronym
MIDAZODOL
Official Title
Clinical Randomized Study of Sublingual Midazolam in Association With Morphine by Oral Route in Arm Fracture in Children at the Emergency Children Care
Study Type
Interventional

2. Study Status

Record Verification Date
August 2013
Overall Recruitment Status
Completed
Study Start Date
January 2007 (undefined)
Primary Completion Date
November 2008 (Actual)
Study Completion Date
February 2009 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
It is a randomized simple-blind monocentric study; the group A will receive oral morphine with placebo and the group B will receive oral morphine with sublingual midazolam. The aim of this study is to show a more important pain decrease in the group taking midazolam versus placebo.
Detailed Description
Fracture is often responsible of pain in the paediatric emergency department (ED). This pain is very severe and needs effective drugs. During a study made at the ED of Necker Enfants Malades Hospital, it has been shown that the oral morphine had a limited action on this kind of pain. Therefore it is interesting to increase the analgesia by making a drug association, for example with the midazolam witch is a benzodiazepine with a sedative and anxiolytic action, and which has got the MMA for the intravenous and the intra rectal forms for children older than 6 months. The intravenous form has some disadvantages like an extra work and an increase of risk of side effects. That is why the sublingual form seems to be interesting in this context. Even if some studies have shown the benefit of midazolam as a preanesthetic medication given to children scheduled for a surgical procedure, none has shown the interest of sublingual midazolam associated with oral morphine to relieve the pain due to a displaced fracture. The aim of this study is to show a more important pain decrease in the group taking midazolam versus placebo. It is a randomized simple-blind monocentric study; the group A will receive oral morphine with placebo and the group B will receive oral morphine with sublingual midazolam . The pain will be quantified thanks to the visual analogical scale (VAS)before and 30 minutes after the drugs administration, and we will try to show a difference of 15 points(on 100) of the VAS at 30 minutes between the two groups. 60 patients aged from 5 to 16 years old and having a displaced fracture will be enrolled in this study which will last 1 year. Patients having a contra-indication for morphine and midazolam won't be enrolled as patients with femoral fracture which needs a local anaesthesia.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Fractures
Keywords
midazolam, sublingual, oral morphine, children, bone fracture, bone fracture with a deformed member

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Experimental
Arm Description
Midazolam and morphine
Arm Title
2
Arm Type
Placebo Comparator
Arm Description
placebo, Nacl 0.9 %, morphine 0.5 mg/kg
Intervention Type
Drug
Intervention Name(s)
Midazolam
Intervention Description
0.2 mg/kg of sublingual midazolam and 0.5 mg/kg of morphine
Intervention Type
Drug
Intervention Name(s)
Placebo
Intervention Description
placebo at 0.2 mg/kg and morphine 0.5 mg/kg
Primary Outcome Measure Information:
Title
Difference in the measurement of pain analogical scale values at 30 minutes between the two groups
Time Frame
after administration until 120 minutes
Secondary Outcome Measure Information:
Title
Pain Analogical scale Values at 15, 30 minutes, 1 hour, 1h30 and 2 hours.
Time Frame
after administration until 120 minutes
Title
Pain Analogical scale Values after the treatment of the fracture
Time Frame
after administration until 120 minutes
Title
Respiratory rate, Oxymetry
Time Frame
after administration until 120 minutes
Title
Conscience (lethargy or irritability)
Time Frame
after administration until 120 minutes
Title
nausea,
Time Frame
after administration until 120 minutes
Title
skin hyperesthesia, rash
Time Frame
after administration until 120 minutes
Title
children cooperation
Time Frame
after surgical procedure

10. Eligibility

Sex
All
Minimum Age & Unit of Time
5 Years
Maximum Age & Unit of Time
16 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: children between 5 and 16 years old children with a disjoined bone fracture children needed oral morphine analgesia written informed consent from one or the two parents or legal pad Exclusion Criteria: ASA score > 2 concomitant administration of oral analgesia (level II WHO classification) less than 6 hours concomitant administration of benzodiazepine less than 24 hours
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gérard CHERON, MD, PhD
Organizational Affiliation
Assistance Publique - Hôpitaux de Paris
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hopital Necker enfants Malade - Department of Pediatric Emergency
City
Paris
ZIP/Postal Code
75015
Country
France

12. IPD Sharing Statement

Citations:
PubMed Identifier
21480984
Citation
Wille-Ledon C, Chappuy H, Giraud C, Treluyer JM, Cheron G. Comparison of a morphine and midazolam combination with morphine alone for paediatric displaced fractures: a randomized study. Acta Paediatr. 2011 Nov;100(11):e203-7. doi: 10.1111/j.1651-2227.2011.02311.x. Epub 2011 May 11.
Results Reference
derived

Learn more about this trial

Efficacy of Sublingual Midazolam in Association With Oral Morphine in Children Analgesia After Bone Fracture

We'll reach out to this number within 24 hrs